Global Regulation and Local Policy Narratives: Making Sense of Dolly
In the last two chapters we described the rise and development of the increasingly differentiated and complex global stem cell economy. Closely related to the operation of the emerging stem cell economy, and regenerative medicine more generally, is a regulatory regime that deals with the multiple societal, legal and ethical challenges in this field. The globalization of stem cell research has heightened pressure to build a regime of regulation that complements globalizing trends in the bioeconomy. But as this and the following chapters will show, a global regime of regulation must deal with the persistence of local policy narratives that until today has led to striking regulatory differences among nations. A central characteristic and challenge of regenerative medicine is the striking contrast in how its projects, ambitions, goals and strategies are perceived and constructed in different countries. In some countries (e.g., the United Kingdom and South Korea), hESC and SCNT research are permitted under certain regulations, but in others (e.g., Germany, Japan and Italy), such research is completely or partially prohibited. We will probe the questions of why such differences exist, whether any signs for a rapprochement between countries are present and what the political implications are for these differences between nations in research and regulation.
KeywordsStem Cell Research Global Regulation Human Cloning Global Politics Embryo Research
Unable to display preview. Download preview PDF.